// App-Quantinova.ai

: Estimating exacerbation rates from routine UK primary care data: an exploratory validation from the IMP2ART programme

Researchers

Presenter

  • Chris Newby

Principal Investigators

  • Neil Wright

  • Sandra Eldridge

  • Susan Morrow

  • Erica Vince-Lawer

  • Francis Appiagyei

  • Tanith Hjelmbjerg

  • Derek Skinner

  • David Price

  • Stephanie J C Taylor

  • Hilary Pinnock

Medical Centers

  • Asthma UK Centre for Applied Research, Centre for Primary Care and Public Health, Blizard Institute, Queen Mary University of London, London, United Kingdom

  • Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom

  • Asthma UK Centre for Applied Research, Usher Institute of Population Health Sciences and Informatics, The University of Edinburgh, Edinburgh, United Kingdom

  • Optimum Patient Care, Cambridge, United Kingdom,

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Asthma

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A